Complete Guide to Moxifloxacin Pediatric Pharmacokinetics
Overview
Moxifloxacin Pediatric is a Fluoroquinolone Antibiotic used in the Tuberculosis therapeutic area. It is indicated for Pediatric Tuberculosis. Interactive pediatric population PK simulator for moxifloxacin in children with rifampicin-resistant tuberculosis. Two-compartment model with transit absorption and allometric scaling from the CATALYST trial (Palmer et al. 2025, Br J Clin Pharmacol).
Key Pharmacokinetic Parameters
This PopPK model for Moxifloxacin Pediatric characterizes the time-course of drug concentrations following Oral administration. Key parameters such as clearance (CL), volume of distribution (Vd), and absorption rate constant (Ka) define the drug's disposition. Use the interactive simulator below to explore these parameters in detail.
Dosing & Administration
Moxifloxacin Pediatric is administered via the Oral route. Oral administration involves absorption from the gastrointestinal tract, and bioavailability may be affected by food intake, formulation, and first-pass metabolism.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Tuberculosis therapeutic area, for the treatment of Pediatric Tuberculosis, understanding the pharmacokinetics of Moxifloxacin Pediatric is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Moxifloxacin Pediatric pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Moxifloxacin Pediatric PK Simulator
Explore Moxifloxacin Pediatric pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Moxifloxacin Pediatric?
The elimination half-life of Moxifloxacin Pediatric depends on patient-specific factors. Use our interactive Moxifloxacin Pediatric PK simulator to explore concentration-time profiles and estimate half-life under different dosing scenarios.
How is Moxifloxacin Pediatric administered?
Moxifloxacin Pediatric is administered via the Oral route. It is indicated for Pediatric Tuberculosis. As a Fluoroquinolone Antibiotic, dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Moxifloxacin Pediatric?
Key pharmacokinetic parameters for Moxifloxacin Pediatric include clearance (CL), volume of distribution (Vd), and elimination half-life. Our interactive simulator uses a PopPK model to characterize the pharmacokinetics of Moxifloxacin Pediatric.
Can I simulate Moxifloxacin Pediatric dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Moxifloxacin Pediatric PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.